4 • 494 Ratings
🗓️ 28 February 2025
⏱️ 35 minutes
🧾️ Download transcript
Click on a timestamp to play from that location
0:00.0 | Bring in show music, please. |
0:04.3 | This is SquawkPod, and I'm CNBC producer Cameron Costa. |
0:08.6 | On today's episode, between Doge and Vida tariffs, the markets were shaky this week. |
0:15.9 | It might be great long term, but near term, it's all at least unsettling. |
0:21.6 | How Wall Street is absorbing the uncertainty, and how Washington, D.C., or Elon Musk, is reassuring investors. |
0:29.6 | The word that Elon Musk used was temporary hardship. |
0:34.6 | Those are two words. |
0:36.6 | And America's first measles-related death in a decade. |
0:41.3 | Dr. Scott Gottlieb on the outbreak in Texas and the risks ahead for a country with declining |
0:46.6 | vaccination rates. |
0:47.8 | And that would be the concern right now, that against the backdrop of declining vaccination |
0:51.4 | rates around the country, you start to see this spread into |
0:54.4 | other pockets where it can continue to spread because you have these communities that have |
0:58.8 | foregone vaccination. |
1:01.1 | Plus, what Monday brings? Foreign tariffs and Oscar wins. Varieties, Cynthia Littleton has all |
1:08.3 | the intel for your viewing party on Sunday. |
1:13.6 | Wicked was huge at the box office. Dune Part 2, huge at the box office. |
1:16.6 | They're both in the best picture race, but they've had very little traction. |
1:21.6 | It's Friday, February 28th, and Squawk Pod begins right now. |
1:30.2 | Stand Becky by in three, two, one. |
1:30.8 | Cure, please. |
1:33.8 | Good morning, everybody. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from CNBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of CNBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.